DSM and University of Georgia to present benefits of lutein and zeaxanthin in enhancing visual performance in upcoming webinar
“The global market for eye health ingredients is projected to increase at a compound annual growth rate (CAGR) of 6 per cent until 2019 ,” said Jens Birrer, Global Marketing Manager at DSM. “Eye health supplements containing lutein and zeaxanthin have typically been aimed at older consumers, with age-related eye conditions identified as a major health concern. The GLARE2 study has been conducted in a younger, healthier population, opening up new markets to the industry as people look to enhance their visual performance through the consumption of nutritional ingredients from an early age.”
Lead author, Professor Billy R. Hammond Jr. and DSM’s Jens Birrer and Wolfgang Schalch will present the latest findings on the GLARE2 study in DSM’s webinar and explain what the new science means to the market. Viewers can click here to register for the early webinar and here for the later showing and get a free infographic.
1 Hammond, B. R., L. M. Fletcher, F. Roos, J. Wittwer and W. Schalch (2014). "A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability and chromatic contrast." Investigational Ophthalmology and Visual Science 55(12): 8583-8589.